Free Newsletter
France to probe GSK, Sanofi vaccination campaign
French authorities are investigating GlaxoSmithKline and Sanofi Pasteur over an anti-hepatitis B vaccination campaign in the 1990s. At issue is whether the companies fully disclosed the shot's potential side effects.
The probe also includes accusations of manslaughter against Sanofi Pasteur MSD, a joint venture of Sanofi Aventis and Merck. The allegations stem from the death of a young woman from multiple sclerosis; the woman had been vaccinated. A Sanofi official called the charges "unjustified," saying that 11 studies have shown no link between the hepatitis B vaccine and MS.
The vaccination campaign in question ran from 1994 to 1998, but then was suspended because of concerns about possible side effects. Thirty plaintiffs have filed civil claims, including the families of five who died after being vaccinated.
- read the story at CNN Money
- read more background at Pharmalot
Related Article:
France picks Gardasil over GSK upstart. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
SHARE
WITH: